Cortland Associates Inc Abb Vie Inc. Transaction History

Cortland Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $212,477 - $233,911	-2,077 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $167,177 - $225,707	2,077 New	2,077 $223,000
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $178,349 - $209,323	-2,076 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $152,316 - $203,821	2,076 New	2,076 $204,000
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $172,473 - $261,490	-2,674 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $192,875 - $241,328	2,674 New	2,674 $237,000
Q1 2019 Apr 26, 2019	SELL	$77.14 - $90.79 $182,358 - $214,627	-2,364 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $2,335 - $2,880	30 Added 1.29%	2,364 $218,000
Q2 2018 Jul 16, 2018	SELL	$89.78 - $106.23 $18,404 - $21,777	-205 Reduced 8.07%	2,334 $216,000
Q1 2018 Apr 26, 2018	BUY	$92.01 - $123.21 $233,613 - $312,830	2,539 New	2,539 $240,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Cortland Associates Inc with notifications on news.